Humanica Public Company Limited (HUMAN) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Humanica Public Company Limited THB 11.57, price THB 4.46, upside +159.4%, quality 79 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Humanica Public Company Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 3.69 THB – 13.60 THB · fair‑value band 6.51 THB – 14.46 THB · the 4.46 THB price screens below the 11.57 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Humanica Public Company in your weekly email
Every Wednesday you see whether Humanica Public Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Humanica Public Company Limited provides human resource outsourcing and payroll services in the Southeast Asia, Thailand, and Indonesia.
Show more
Humanica Public Company Limited provides human resource outsourcing and payroll services in the Southeast Asia, Thailand, and Indonesia. The company provides Workplaze HCM Core, a tool which manages employee records, organizational structures, and key HR processes; Workplaze OKR, a goal-setting frameworks for workplace; Workplaze Payroll, an automated payroll solution; Workplaze Time, a time management tool; Workplaze HR Training Management, a management tool for reskilling and upskilling; Workplaze Talent Management, a solution which align people and performance strategies; Workplaze HR Recruitment Management, a platform to plan workforce, post jobs across channels, manage applications, and collaborate with hiring teams; Workplaze Analytics & Reporting; Workplaze Benefits Management, a benefit management solution; Workplaze Mobile, a solution which provides comfort to perform HR tasks anytime and anywhere; and ERP, a solution which streamlines workflow and minimize mistakes, as well as HR solutions for the mid-market segment. The company also provides implementation services for human resource systems, computer software for enterprise resource planning, and access control devices, as well as offers life and non-life insurance brokerage services. In addition, it offers services, such as accounting and financial outsourcing, human resource system consultants, enterprise resource planning, human resources consulting and training, project implementation and customization, systematizing personnel and payroll and selling access control equipment, and benefits administration services; and offers software-as-a-service and on-premises solutions. The company was founded in 2003 and is headquartered in Bangkok, Thailand.
Stock analysis
Humanica Public Company Limited (HUMAN) currently trades at 4.46 THB, while our model-based Fair Value estimate is 11.57 THB, implying the stock looks roughly 61.5% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 11.90 THB per share, and 20 of the 26 models we run sit above the 4.46 THB price.
Bear case: the Asset-Based group reads lowest at 2.67 THB, and 6 of the 26 models stay below the price. Evidence for this calculation is low.
Scenario range: 6.51 THB (bear) to 14.46 THB (bull), the price of 4.46 THB sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 79/100 (high quality), in the Technology sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Humanica Public Company Limited reported revenue of 1.5B THB in FY2025 versus 729M THB in FY2021, a compound +20.2%/yr. Reported net income was 346M THB in FY2025, compounding +19.4%/yr from FY2021.
Key figures
Market cap 3.8B THB (≈ $113M) · P/E ratio 10.9 · P/S ratio 2.47 · EPS (TTM) 0.4100 THB · Dividend yield 7.2% · Net margin 22.7% · Return on equity 9.5% · Return on assets (EBIT) 8.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 26% below its 52-week high and 21% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −14% fair-value upside, at 159%, HUMAN screens cheaper than that median.
Fair Value models
Bear 6.51 THBFair Value 11.57 THBBull 14.46 THB
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.0661 THB per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+6.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.1%
Start year 2020 (pandemic). Over 10 years: +20.5% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.0%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in THB ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in THB: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+18.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+10.8%
Dividend (yield on the price)7.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.11% vs 2%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.26% → 27%
Start year 2020 (pandemic)
⚠ Revenue per share shrinking 2.0%/yr over ~10Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−0.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Thailand: IMF forecast 1.2% a year to 2030, 1.1% from 2016 to 2025) that is about −1.6% a year for the price.
Compare Humanica Public Company Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software - Application · 720 stocks
Beats the industry median on 13/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score79 · Top 25%
Fair Value upside+159% · Top 25%
Profitability
Return on equity (TTM)9% · Above median
Return on assets6% · Top 25%
Net margin (TTM)21% · Top 25%
Operating margin (TTM)23% · Top 25%
Growth and dividend
Revenue growth15% · Above median
Dividend yield (TTM)7.2% · Top 25%
Balance sheet
Debt / equity0.00× · Lowest 25%
Valuation Multiplesvs Software - Application median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Humanica Public Company Limited Fair Value". https://www.fairvalue-calculator.com/stock/HUMAN
Frequently asked questions
Is Humanica Public Company Limited (HUMAN) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 11.57 THB versus a price of 4.46 THB, about +159% upside (undervalued).
What is the fair value of HUMAN?
Our model-based fair value for Humanica Public Company Limited is 11.57 THB (as of Sep 24, 2026), built from audited fundamentals. The current price: 4.46 THB.
What is the quality score of HUMAN?
Humanica Public Company Limited has a Quality Score of 79/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Humanica Public Company Limited (HUMAN)?
Our model-based price target is the fair value of 11.57 THB (as of Sep 24, 2026) from 26 valuation models. Cautious scenario 6.51 THB, optimistic scenario 14.46 THB. It is a calculation from audited fundamentals, not an analyst target.
What is the Humanica Public Company Limited stock forecast for 2026?
Our models put fair value at 11.57 THB, about +159% upside versus a price of 4.46 THB (undervalued). Cautious scenario 6.51 THB, optimistic scenario 14.46 THB. The calculation is refreshed regularly with new filings.
What is the revenue of Humanica Public Company Limited (HUMAN)?
Humanica Public Company Limited reported trailing-twelve-month revenue of about 1.6B THB (latest available figure, as of Sep 24, 2026).
Does Humanica Public Company Limited pay a dividend?
Humanica Public Company Limited currently shows a dividend yield of about 7.17% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Humanica Public Company Limited (HUMAN)?
For today's price to be fair in a discounted-cash-flow model, Humanica Public Company Limited would have to grow free cash flow by -0.5 % per year for five years (discount rate 13.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +16.2 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of HUMAN use?
Our models discount Humanica Public Company Limited at 13.1 %: a base by market capitalisation (micro), damped by beta 0.58, country premium for Thailand. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Humanica Public Company Limited that is -0.5 % per year a year over ten years, using the same discount rate (13.1 %) and the same formula as our fair value.
How much growth has Humanica Public Company Limited (HUMAN) delivered so far?
Over the past 5 years revenue at Humanica Public Company Limited grew +16.2 % a year. The price currently implies -0.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Humanica Public Company Limited (HUMAN) growing?
The median revenue growth in the sector is +8.2 % a year. That is the yardstick for the growth priced into Humanica Public Company Limited (-0.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Humanica Public Company Limited (HUMAN)?
The free-cash-flow yield on the price is 10.48 %: that much free cash flow Humanica Public Company Limited produces per unit of market value. When it exceeds the discount rate of our models (13.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Humanica Public Company Limited (HUMAN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Humanica Public Company Limited it is 11.57 THB per share (as of Sep 24, 2026), against a price of 4.46 THB. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Humanica Public Company Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, HUMAN trades below its calculated fair value: price 4.46 THB, fair value 11.57 THB, a gap of about +159% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HUMAN?
No. The price is what the market pays today (4.46 THB); the fair value is what the company's own numbers justify (11.57 THB). For Humanica Public Company Limited the two are 7.11 THB per share apart. That gap is exactly why we show both numbers side by side.
How much is Humanica Public Company Limited worth?
The market values Humanica Public Company Limited at about 3.8B THB (market capitalisation, as of Sep 24, 2026). Per share that is 4.46 THB; our models calculate a fair value of 11.57 THB per share.
What do the bullish and bearish scenarios say about HUMAN?
Our models span a range for Humanica Public Company Limited: cautious scenario 6.51 THB, base 11.57 THB, optimistic 14.46 THB per share (as of Sep 24, 2026, price 4.46 THB). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of HUMAN?
Humanica Public Company Limited trades at a price-to-earnings ratio of 10.9 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 11.57 THB is built from several models across several years. Other multiples: PEG 1.3, P/B 1.1, P/S 2.4, EV/EBITDA 7.0.
What is the PEG ratio of HUMAN?
The PEG ratio of Humanica Public Company Limited is 1.31 (P/E divided by earnings growth, as of Sep 24, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Humanica Public Company Limited (HUMAN)?
Balance-sheet figures for Humanica Public Company Limited (as of Sep 24, 2026): return on equity 9.5%, debt of 0.00 per unit of equity. They feed the Quality Score of 79/100, which measures business quality independently of the share price.
How far is HUMAN from its 52-week high?
Humanica Public Company Limited trades at 4.46 THB, about 26% below its 52-week high of 6.01 THB and 21% above the low of 3.69 THB (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 11.57 THB is for.
Which stocks are comparable to Humanica Public Company Limited?
From the same area (Technology) we also value SAP SE, Shopify Inc, Uber Technologies, Inc, Salesforce, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Humanica Public Company Limited stock attractive at the current price?
The data as of Sep 24, 2026: price 4.46 THB, calculated fair value 11.57 THB (+159%), Quality Score 79/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of HUMAN calculated?
We run Humanica Public Company Limited through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 11.57 THB, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Humanica Public Company Limited currently trades 159 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Humanica Public Company Limited (HUMAN)?
The closing price on Sep 24, 2026 was 4.46 THB. Our model-based fair value is 11.57 THB, about +159% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Humanica Public Company Limited right now?
The rarer combination: high quality (79/100) AND below fair value. That earns a closer look rather than a quick verdict. The price is below even our cautious bear case (6.51 THB). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (6.51 THB to 14.46 THB) leaves room in how you read the outcome.
Where does the earnings growth of Humanica Public Company Limited (HUMAN) come from?
Earnings per share at Humanica Public Company Limited grew −4.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share −7.9 %, EBIT margin +3.7 %, tax rate −1.5 %, residual (interest, one-offs) +1.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Humanica Public Company Limited
How large is the market capitalisation of Humanica Public Company Limited (HUMAN)?
The market capitalisation of Humanica Public Company Limited is 3.8B THB (≈ $113M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Humanica Public Company Limited (HUMAN)?
The price-to-sales ratio of Humanica Public Company Limited is 2.47 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Humanica Public Company Limited (HUMAN)?
Earnings per share at Humanica Public Company Limited are 0.4100 THB (price ÷ EPS = P/E 10.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Humanica Public Company Limited (HUMAN)?
The dividend yield of Humanica Public Company Limited is 7.2% (payout 78.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Humanica Public Company Limited (HUMAN)?
The net margin of Humanica Public Company Limited is 22.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Humanica Public Company Limited (HUMAN)?
The return on equity (ROE) of Humanica Public Company Limited is 9.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Humanica Public Company Limited (HUMAN)?
On an EBIT basis the return on assets of Humanica Public Company Limited is 8.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Humanica Public Company Limited (HUMAN)?
The operating margin of Humanica Public Company Limited is 22.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Humanica Public Company Limited (HUMAN)?
Revenue at Humanica Public Company Limited is growing +14.6% versus a year earlier (3y avg +13.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net cash does Humanica Public Company Limited (HUMAN) hold?
Humanica Public Company Limited holds more cash than debt, 318M THB net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Humanica Public Company Limited in the live analysis
One click puts Humanica Public Company Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
